NYSE:LLYPharmaceuticals
Eli Lilly (LLY) Net Margin At 31.7% Tests Justification For 40.5x P/E Narrative
Eli Lilly (LLY) just followed up a strong 2025 with Q1 2026 results that sit on top of full year revenue of US$65.2b and basic EPS of US$23.00 for the trailing twelve months, underpinned by net income of US$20.6b. Over recent quarters the company has seen revenue move from US$13.5b in Q4 2024 to US$19.3b in Q4 2025, while quarterly basic EPS shifted from US$4.88 to US$7.39. This gives a clear sense of the scale at which earnings are now being generated as margins tighten the focus on...